益生股份(002458.SZ):與得利斯、濟南舜騰簽署戰略合作協議
格隆匯10月10日丨益生股份(002458.SZ)公佈,公司於近日與山東得利斯食品股份有限公司(“得利斯”)和濟南舜騰股權投資管理有限公司(“濟南舜騰”)簽署了《戰略合作協議》,三方就生豬全產業鏈合作事項達成戰略共識。
公司此次與得利斯和濟南舜騰簽署《戰略合作協議》,規劃在山東省內建設規模化、綠色、低碳生豬養殖、屠宰、食品加工及銷售門店的全產業鏈項目,公司負責上述項目上游端種豬場項目的建設與運營,在公司不斷擴展種豬飼養規模的戰略背景下,該協議的簽署有利於為公司未來種豬的銷售提供穩定的銷售渠道,增加種豬的銷量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.